Wheat Belly (Revised and Expanded Edition)

by William Davis

  14. Blount BC, Pirkle JL, Osterloh JD et al. Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Environ Health Perspect 2006 Dec; 114(12):1865–71.

  15. Schmutzler C, Gotthardt I, Hofmann PJ et al. Endocrine disruptors and the thyroid gland—a combined in vitro and in vivo analysis of potential new biomarkers. Environ Health Perspect 2007 Dec; 115 (Suppl 1):77–83.

  16. Katagiri R, Asakura K, Sasaki S et al. Estimation of habitual iodine intake in Japanese adults using 16-day diet records over four seasons with a newly developed food composition database for iodine. Br J Nutr 2015 Aug 28; 114(4):624–34.

  17. Dasgupta PK, Liu Y, Dyke JV. Iodine nutrition: iodine content of iodized salt in the United States. Environ Sci Technol 2008 Feb 15; 42(4):1315–23.

  18. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005 Sep; 90(9):5483–8.

  19. De Coster S, van Larebeke N. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health 2012; 2012:713696.

  20. National Research Council, 2000. Toxicological effects of methylmercury. at https://www.nap.edu/read/9899/chapter/2.

  21. Consumer Lab, 2018: Product review: fish oil and omega-3 and -7 fatty acid supplements review at https://www.consumerlab.com/reviews/fish_oil_supplements_review/omega3.

  22. Raatz SK, Silverstein JT, Jahns L, Picklo MJ. Issues of fish consumption for cardiovascular disease risk reduction. Nutrients 2013 Mar 28 [Epub ahead of print].

  23. Mariani J, Doval HC, Nul D et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2013 Feb 19; 2(1):e005033.

  24. Miles EA, Calder PC. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr 2012 Jun; 107 (Suppl 2):S171–84.

  25. Laviano A, Rianda S, Molfino A et al. Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care 2013 Mar; 16(2):156–61.

  26. Chiu CC, Su KP, Cheng TC. The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 2008 Aug 1; 32(6):1538–44.

  27. Buoite Stella A, Gortan Cappellari G, Barazzoni R, Zanetti M. Update on the impact of omega 3 fatty acids on inflammation, insulin resistance and sarcopenia: a review. Int J Mol Sci 2018 Jan 11; 19(1):E218.

  28. Schunck WH, Konkel A, Fischer R, Weylandt KH. Therapeutic potential of omega-3 fatty acid–derived epoxyeicosanoids in cardiovascular and inflammatory diseases. Pharmacol Ther 2018 Mar; 183:177–204.

  29. Nielsen FH. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev 2010 Jun; 68(6):333–40.

  30. Thomas D. A study on the mineral depletion of the foods available to us as a nation over the period 1940 to 1991. Nutr Health 2003; 17(2):85–115.

  31. Bohn T, Davidsson L, Walczyk T, Hurrell RF. Phytic acid added to white-wheat bread inhibits fractional apparent magnesium absorption in humans. Am J Clin Nutr 2004 Mar; 79(3):418–23.

  32. Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 2012 Mar; 70(3):153–64.

  33. Hovdenak N, Haram K. Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 2012 Oct; 164(2):127–32.

  34. Stendig-Lindberg G, Tepper R, Leichter I. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res 1993; 6(2):155–63.

  35. Genuis SJ, Bouchard TP. Combination of Micronutrients for Bone (COMB) Study: bone density after micronutrient intervention. J Environ Public Health 2012; 2012:354151.

  36. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012 Apr; 66(4):411–8.

  37. Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol 2018 Jun; 26(6):484–97.

  38. Burton M, Cobb E, Donachie P et al. The effect of handwashing with water or soap on bacterial contamination of hands. Int J Environ Res Public Health 2011 Jan; 8(1): 97–104.

  39. Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis 2013 Sep; 4(5):223–31.

  40. Schnorr SL, Candela M, Rampelli S et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun 2014 Apr 15; 5:3654.

  41. Obregon-Tito AJ, Tito RY, Metcalf J et al. Subsistence strategies in traditional societies distinguish gut microbiomes. Nat Commun 2015; 6:6505.

  42. Feng Q, Chen WD, Wang YD. Gut microbiota: an integral moderator in health and disease. Front Microbiol 2018 Feb 21; 9:151.

  43. Erdman SE, Poutahidis T. Microbes and oxytocin: benefits for host physiology and behavior. Int Rev Neurobiol 2016; 131:91–126.

  44. Choung RS, Locke GR, Schleck CD et al. Associations between medication use and functional gastrointestinal disorders: a population-based study. Neurogastroenterol Motil 2013 May; 25(5):413–9.

  45. Chassaing B, Gewirtz AT. Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol Pathol 2014 Jan; 42(1):49–53.

  46. Suez J, Korem T, Zilberman-Schapira G et al. Non-caloric artificial sweeteners and the microbiome: findings and challenges. Gut Microbes 2015; 6(2):149–55.

  47. Ghoshal UC, Shukla R, Ghoshal U. Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. Gut Liver 2017 Mar 15; 11(2):196–208.

  48. Pimentel M, Wallace D, Hallegua D et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004 Apr; 63(4):450–2.

  49. Chedid V, Dhalla S, Clarke JO et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med 2014 May; 3(3):16–24.

  50. Muir JG, O’Dea K. Measurement of resistant starch: factors affecting the amount of starch escaping digestion in vitro. Am J Clin Nutr 1992 Jul 1; 56(1):123–7.

  51. Jenkins DJ, Cuff D, Wolever TM et al. Digestibility of carbohydrate foods in an ileos-tomate: relationship to dietary fiber, in vitro digestibility, and glycemic response. Am J Gastroenterol 1987 Aug; 82(8):709–17.

  52. Murphy MM, Douglass JS, Birkett A. Resistant starch intakes in the United States. J Am Diet Assoc 2008; 108(1): 67–78.

  CHAPTER 16

  1. Sherman SB, Sarsour N, Salehi M et al. Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis. Gut Microbes 2018; 9(5):400–21.

  2. Item F, Konrad D. Visceral fat and metabolic inflammation: the portal theory revisited. Obes Rev 2012 Dec; 13 (Suppl 2):30–9.

  3. Lautenbach A, Budde A, Wrann CD. Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells. Nutr Cancer 2009; 61(4):484–91.

  4. Di Dalmazi G, Pasquali R, Beuschlein F, Reincke M. Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur J Endocrinol 2015 Oct; 173(4):M61–71.

  5. Phy JL, Pohlmeier AM, Cooper JA et al. Low starch/low dairy diet results in successful treatment of obesity and co-morbidities linked to polycystic ovary syndrome (PCOS). J Obes Weight Loss Ther 2015 Apr; 5(2):259.

  6. Liu R, Zhang C, Shi Y et al. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome. Front Microbial 2017 Feb 28; 8:324.

  7. Phy et al. J Obes Weight Loss Ther 2015 Apr; 5(2):259.

  8. Gholizadeh Shamasbi S, Dehgan P, Mohammad-Alizadeh Charandabi S et al. The effect of resistant dextrin
as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Eur J Nutr 2018 Feb 26 [Epub ahead of print].

  9. Mazur A, Westerman R, Mueller U. Is rising obesity causing a secular (age-independent) decline in testosterone among American men? PLoS One 2013 Oct 16; 8(10):e76178.

  10. Pilz S, Frisch S, Koertke H et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res 2011 Mar; 43(3):223–5.

  11. Schneider G. Kirschner MA, Berkowitz R, Ertel NH. Increased estrogen production in obese men. J Clin Endocrinol Metab 1979 Apr; 48(4):633–8.

  12. De Lorenzo A, Noce A, Moriconi E et al. MOSH Syndrome (Male Obesity Secondary Hypogonadism): clinical assessment and possible therapeutic approaches. Nutrients 2018 Apr 12; 10(4):E474.

  13. Rosen RC, Wu F, Behre HM et al. Quality of life and sexual function benefits of long-term testosterone treatment: longitudinal results from the Registry of Hypogonadism in Men (RHYME). J Sex Med 2017 Sep; 14(9):1104–15.

  EPILOGUE

  1. Diamond J. The worst mistake in the history of the human race. Discover 1987 May; 95–8.

  2. Roberts C, Manchester K. Dental disease. In The Archaeology of Disease. New York: Cornell University Press, 2005; 63–83.

  3. Cohen MN, Crane-Kramer GMM, editors’ summation. In Ancient Health: Skeletal Indicators of Agricultural and Economic Intensification. Gainesville: University Press of Florida, 2007; 32043.

  4. Wallace IJ, Worthington S, Felson DT et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci USA 2017 Aug 29; 114(35):9332–6.

  What’s next on

  your reading list?

  Discover your next

  great read!

  Get personalized book picks and up-to-date news about this author.

  Sign up now.